Publication:
Changes of liver functions after albendazole treatment in human gnathostomiasis

dc.contributor.authorS. Inkatanuvaten_US
dc.contributor.authorP. Suntharasamaien_US
dc.contributor.authorS. Vutikesen_US
dc.contributor.authorM. Rigantien_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2018-07-04T08:09:33Z
dc.date.available2018-07-04T08:09:33Z
dc.date.issued1998-12-15en_US
dc.description.abstractNinety-eight out-patients of the Hospital for Tropical Diseases, Bangkok with clinical diagnosis of cutaneous gnathostomiasis were studied. All patients were treated with albendazole at a dosage of 400 mg (two tablets) twice daily for 14 days. They were seen periodically on day 0, day 14, day 28, day 195 and 1 year treatment with laboratory investigations for any side effects of the treatment. There was a statistically significant increase of total protein, albumin, alkaline phosphatase (ALP), aspartate aminotransferase (AST) and alanine aminotransferase (ALT) values when comparing the different periods. The abnormal results are clearly indicated in AST and ALT values (liver enzyme) especially on day 14 both male and female patients had highest levels. No significant association with time was found in ALP value.en_US
dc.identifier.citationJournal of the Medical Association of Thailand. Vol.81, No.10 (1998), 735-740en_US
dc.identifier.issn01252208en_US
dc.identifier.other2-s2.0-0031771724en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/18432
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0031771724&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleChanges of liver functions after albendazole treatment in human gnathostomiasisen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=0031771724&origin=inwarden_US

Files

Collections